Propanc Biopharma reports total assets of $19.6M as of June 30

As a result of significant changes to its financial position during the year, the Company was able to complete an initial public offering and uplisting to Nasdaq on August 14, 2025. These developments are expected to support future operational and research activities. James Nathanielsz, Propanc’s CEO stated, “The Company is focused on advancing our lead therapeutic candidate and further building our intellectual property portfolio with various development milestones anticipated by the end of 2025 and throughout 2026. We are also actively engaged in collaborative efforts with regards to our clinical pipeline.” Mr. Nathanielsz concludes, “In addition, we intend to create a $100 Million or greater, digital asset treasury over the next twelve months. As of late 2025, there are over 200 public companies holding digital assets in their treasuries, with estimates ranging from over 150 to more than 200 firms. These Digital Asset Treasury Companies hold billions of dollars in cryptocurrencies, primarily Bitcoin, but increasingly also Ethereum, Solana, and other altcoins, as a strategic corporate asset per Morningstar.”